This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignees: Children's Medical Center Corporation, Ganna Bio, Inc.. Active years: 2023.
Company Filing History:
1 out of 1,072 
1 out of 1 Years Active: 2023
Title: Mohui Wei: Innovator in Glycan-Modified Nucleic Acids
Introduction
Mohui Wei is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of glycan-modified nucleic acids. His innovative work has the potential to impact pharmaceutical compositions and therapeutic methods.
Latest Patents
Mohui Wei holds a patent for "Glycan modified short interfering RNA." This patent relates to glycan-modified nucleic acids, including short interfering RNA molecules. The glycan-modified nucleic acids feature an oligosaccharide moiety that is bonded to the nucleic acid and contains a multiple antennary complex type N-glycan. The patent also discusses pharmaceutical compositions containing such glycan-modified nucleic acids, along with methods for their production and application.
Career Highlights
Throughout his career, Mohui Wei has worked with notable organizations, including Ganna Bio, Inc. and Children's Medical Center Corporation. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research.
Collaborations
Some of Mohui Wei's coworkers include Ryan A Flynn and Brian Goodman. Their collaborative efforts have contributed to advancements in the biotechnology sector.
Conclusion
Mohui Wei's innovative work in glycan-modified nucleic acids showcases his dedication to advancing biotechnology. His contributions have the potential to lead to significant developments in pharmaceutical applications.